Table 1.
Baseline characteristics of the study group
| Variable | Value |
|---|---|
| Total patients | 131 |
| Age, yr | 66.6 ± 11.7 |
| Sex | |
| Men | 74 (56.5) |
| Female | 57 (43.5) |
| Hepatitis | |
| HBV | 19 (14.5) |
| HCV | 4 (3.1) |
| TNM stage | |
| I | 19 (14.5) |
| II | 13 (9.9) |
| III | 3 (2.3) |
| Iva | 45 (34.4) |
| IVb | 51 (38.9) |
| Curative surgery | 37 (29.1) |
| Chemotherapy | |
| Adjuvant | 16 (12.7) |
| Palliative | 62 (49.2) |
| Survival, day | 213 (104.0–440.0) |
Values are presented as mean ± SD, number (%), or median (interquartile range).
HBV, hepatitis virus B; HCV, hepatitis virus C; TNM, tumor-node-metastasis.